NCT06467578

Brief Summary

Obesity is a leading risk factor for chronic diseases such as type 2 diabetes, cancer, and cardiovascular disease. Generic weight management programs that target dietary intake and physical activity have been shown to be ineffective in maintaining weight loss beyond a 6-month period. Personalizing weight management programs produces more weight loss than generic programs, possibly through improved self-efficacy (confidence in one's ability to control weight through behavior). One way to personalize diet goals for individuals is by resting metabolic rate (RMR; 'metabolism'). This study will explore adherence and satisfaction of 6-weeks repeated at-home measures of metabolism using a portable device in healthy adults with and without obesity. Relationships among adherence and satisfaction outcomes to health behavior variables will be explored using dietary recalls, exercise monitors and questionnaires. Investigators will conduct a 6-week, one-arm feasibility study in order to address these questions. Twenty men and women ages 19-65 will be recruited (up to n=25 participants), among which 10 participants will have a body mass index (BMI) of ≥30kg/m2 (classified as having obesity), and the remaining 10 participants will have a body mass index (BMI) of \< 29.9kg/m2 (classified as not having obesity). The baseline study visit will evaluate participant's anthropometric measures, RMR using the ParvoMedics TrueOne 2400 and Breezing indirect calorimeters, psychological and behavioural related parameters. An activPAL device will be provided to measure participant physical activity. Completion of a 3-day diet record following the baseline study visit, in which participants keep a record of all food and beverages consumed over 2 weekdays and 1 weekend, is required. Participants will be asked to use the Breezing device from home to measure their RMR one time/week on the same day of the week (± one day) and at the same time each morning for six consecutive weeks following the baseline visit. A weekly Qualtrics survey will be sent to participants to monitor adherence. A follow-up visit after the six weeks will assess participant's body composition using a Dual X-ray Absorptiometry (DEXA), in addition to completion of a user satisfaction interview with a study team member for descriptive analysis. The measures taken at the baseline study visit will be repeated at the follow-up visit.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2024

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

June 24, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

May 13, 2024

Last Update Submit

June 20, 2024

Conditions

Keywords

resting metabolic rateportable indirect calorimeterfeasibilityacceptability

Outcome Measures

Primary Outcomes (3)

  • Adherence

    Qualtrics survey

    6 weeks

  • RMR (portable indirect calorimeter - BreezingTM)

    Using Breezing device

    6 weeks

  • Satisfaction & feedback (feasibility)

    In-person interview

    6 weeks

Secondary Outcomes (11)

  • Resting metabolic rate (RMR) - metabolic cart indirect calorimeter

    6-8 weeks

  • Dietary intake

    3 days

  • Physical activity (accelerometry-derived patterns in moderate-to-vigorous activity)

    7 days post-baseline and 7 days pre-follow-up

  • Self-regulation

    6-8 weeks

  • Eating behaviours

    6-8 weeks

  • +6 more secondary outcomes

Study Arms (1)

Breezing Portable Indirect Calorimeter

OTHER

Use Breezing to assess RMR once a week for six weeks

Device: Breezing Portable Indirect Calorimeter

Interventions

Indirect calorimeter with face mask and smartphone compatible application

Breezing Portable Indirect Calorimeter

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 19-65 years
  • Ability to read, understand, and speak in English
  • BMI over 18.5
  • Live within a 1-hour radius of UBCO
  • Sedentary or recreationally active, defined as: \<300-minutes per week of self-reported voluntary exercise at moderate intensity or greater over the past 12-weeks
  • Not currently pregnant or lactating, not planning to become pregnant in the next 12 weeks
  • Ability to attend two in-person sessions at UBCO
  • Ability and willingness to fast for 12 hours before each study day visit and at least once a week before completing RMR measures using the portable indirect calorimeter
  • Access to a mobile device (i.e., smartphone or tablet) with reliable Bluetooth and Wi-Fi connection for the 6 week study duration
  • If applicable:
  • For people who occasionally (i.e., \<1x/day) use cannabis (including cannabidiol-based products): ability and willingness to abstain from cannabis for two days prior to each study day visit, and the morning of each study visit.
  • For people who use cannabis daily: ability and willingness to continue to use the exact same amount of cannabis as they normally use for two days prior to each study day visit, the morning of each study visit (if applicable), and during the 6 week study duration.

You may not qualify if:

  • Current or previous major comorbidities, by self-report, including:
  • Cardiovascular disease
  • Diabetes (type 1, type 2, pervious gestational)
  • Cancer
  • Thyroid diseases
  • Human immunodeficiency virus or hepatitis B or C
  • Renal diseases
  • Polycystic ovary syndrome
  • Uncontrolled/untreated, by self-report:
  • Hypertension
  • Dyslipidemia
  • Sleep disorders
  • Severe depression
  • Any other condition that may affect energy balance
  • Currently or in the past six months:
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia - Okanagan Campus

Kelowna, British Columbia, V1V1V7, Canada

RECRUITING

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Central Study Contacts

Sarah Purcell, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 13, 2024

First Posted

June 21, 2024

Study Start

April 19, 2024

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

June 24, 2024

Record last verified: 2024-06

Locations